Abstract
The treatment of invasive fungal infections has deeply evolved in the last years with the inclusion of new antifungals, mainly new azoles (i.e., posaconazole, isavuconazole), to the therapeutic armamentarium. This review focuses on the role of isavuconazole for treating the most important invasive fungal infections both in animals and humans (hematological and non-hematological patients).
Lingua originale | English |
---|---|
pagine (da-a) | 209-215 |
Numero di pagine | 7 |
Rivista | Journal of Fungi |
Volume | 6 |
DOI | |
Stato di pubblicazione | Pubblicato - 2020 |
Keywords
- Isavuconazole
- antifungal prophylaxis
- antifungal treatment